EcoR1 Capital
Venture capital · San Francisco, California, United States
Portfolio collected from the firm’s website, last checked Jul 26, 2026.Raises and exits come from each company’s own SEC and company records.
11Deep-tech portfolio2 active
9Portfolio exitsAcquired or listed
0Raises, 12 monthsLatest: Alumis
63Co-investorsShare a portfolio company
Portfolio · 11 companies
| Company | Sector | Status | Latest raise | Raised |
|---|---|---|---|---|
| Prelude Therapeutics | Biotech | Active | Aug 28, 2020 | $97.0M |
| Kymera Therapeutics | Biotech | Active | — | — |
| Alumis | Biotech | Public | Jul 24, 2024 | $240.0M |
| Relay Therapeutics | Biotech | Public | Jan 10, 2024 | $30.0M |
| Absci | Biotech | Public | Mar 30, 2021 | $216.0M |
| Edgewise Therapeutics | Biotech | Public | Dec 10, 2020 | $120.1M |
| Imago BioSciences | Biotech | Acquired | Nov 20, 2020 | $105.8M |
| iTeos Therapeutics | Biotech | Acquired | Apr 9, 2020 | $125.4M |
| Revolution Medicines | Biotech | Public | Nov 15, 2019 | $204.2M |
| Attovia Therapeutics | Biotech | Public | — | — |
| Turning Point Therapeutics | Biotech | Acquired | — | — |
Peer ranks
Portfolio size#44
Portfolio exits#13
Raises, 12 months#88
Co-investors#18
Co-investors
- Biotechnology Value FundVenture capital6 shared
- Bay City CapitalVenture capital4 shared
- Boxer CapitalVenture capital4 shared
- Brookside CapitalVenture capital4 shared
- Frazier Healthcare PartnersVenture capital4 shared
- The Column GroupVenture capital4 shared
- Atlas VentureVenture capital3 shared
- Deerfield Capital ManagementVenture capital3 shared
- Gurnet Point CapitalVenture capital3 shared
- Logos CapitalVenture capital3 shared
Sectors
- Biotech11
Portfolios are collected from investors’ own websites and matched to tracked deep-tech companies by name; duplicate listings of the same firm are merged. Exits and raises come from each company’s own record: Form D through the latest filing.